C. elegans screening strategies to identify pro-longevity interventions.

Area of Science:

• Biogerontology
• Genetics
• Pharmacology

Background:

• Single-cell drug screenings are limited for organismal effects.
• Model organisms like Caenorhabditis elegans offer advantages for modifier screenings.
• C. elegans exhibits reproducible phenotypes under mitochondrial stress.

Purpose of the Study:

• To develop and apply a high-throughput screening strategy in C. elegans for identifying pro-longevity compounds.
• To leverage organismal-level responses to mitochondrial stress for drug discovery.

Main Methods:

• Utilized Caenorhabditis elegans as a model organism for drug screening.
• Developed a screening strategy based on quantifiable phenotypic readouts of mitochondrial stress.
• Employed the Cellomics ArrayScanVTI-HCS Reader for high-content analysis.

Main Results:

• Identified specific, quantifiable phenotypic changes in C. elegans associated with varying degrees of mitochondrial stress.
• Successfully identified a novel pro-longevity drug candidate using the developed screening approach.

Conclusions:

• Caenorhabditis elegans is a powerful model for organismal-level drug screening, particularly for lifespan extension.
• The developed screening strategy effectively identifies compounds that modulate mitochondrial stress to promote longevity.